In a scientific statement published in the International Journal of Stroke, the organization summarises the latest evidence on the association between stroke and the environmental factors exacerbated by climate change. These include extreme temperatures, temperature variability, humidity, barometric pressure, wildfires, and dust and sandstorms.
Senior lead author Professor Anna Ranta from the Department of Medicine at the University of Otago, Wellington, New Zealand, and a member of the World Stroke Organization’s Board of Directors, said an unstable climate increases the risk both of having a stroke and of patients dying as a result.
“Absolute changes in temperature and variations in temperature, barometric pressure and humidity – patterns that are intensifying as a result of climate change – all have an impact on stroke risk” Ranta added.**
Professor Ranta stated that compound weather events, such as when extreme heat and drought, or cold, humidity and wind come together, have an additive effect, increasing the risk of stroke and mortality even further.
“Air pollution is another big factor in increasing the risk of stroke, with more than 20 per cent of strokes globally attributed to air pollution.
Older adults, workers frequently exposed to the weather, and those in low and middle-income countries are at higher risk of stroke from environmental factors.
The World Stroke Organization’s statement says advancing efforts to reduce greenhouse gas emissions is vital to reduce the environmental drivers of stroke risk and to protect long-term population brain health.
The scientific paper was put together by an international panel, led by Professor Ranta, and included experts in climate change and climate medicine, and stroke specialists from New Zealand, Asia, Europe, the Middle East and North Africa, and North and South America.
Citation #
- The study Stroke and climate change: A World Stroke Organization scientific statement was published in International Journal of Stroke. Authors: Ali Saad, Maria Khan, Conrado Estol, Mohammad Wasay, Tomoaki Kameda, Teresa Ullberg, Yannick Béjot, Serefnur Ozturk, Maria Epifania Collantes, Carol Zavaleta-Cortijo, Janice Kang, Alexandra Macmillan, Daniel G Kingston, Janet Stephenson, Jacques Reis, and Anna Ranta
Declaration of conflicting interests #
The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Yannick Béjot reports personal fees from BMS, Pfizer, Medtronic, Boehringer-Ingelheim, Amgen, Servier, NovoNordisk, Novartis, and Argenx outside the submitted work.
Funding #
The authors received no financial support for the research, authorship, and/or publication of this article.
Contact [Notaspampeanas](mailto: notaspampeanas@gmail.com)